Analysis of clinical NSCLC tumor specimens confirmed elevated LAPTM4B protein expression in EGFR-mutant (exon 19 deletion) samples, relative to EGFR wild-type samples. The gene discussed is LAPTM4B; the disease is non-small cell lung carcinoma.